BG
VTVT icon

BlackRock Group’s vTv Therapeutics VTVT Stock Holding History

BlackRock Group’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$159K Hold
823
– – ﹤0.01% 2725
2016
Q3 		$237K Hold
823
– – ﹤0.01% 2573
2016
Q2 		$191K Hold
823
– – ﹤0.01% 2595
2016
Q1 		$170K Hold
823
– – ﹤0.01% 2624
2015
Q4 		$224K Buy
823
+317
+63% +$89K ﹤0.01% 2494
2015
Q3 		$132K Buy
+506
New +$176K ﹤0.01% 2632

Other funds holding VTVT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

BlackRock Group's VTVT Position: Q4 2016 in Review

BlackRock Group held its vTv Therapeutics (VTVT) position steady in Q4 2016 at 823 shares worth $159K. The position accounts for ﹤0.01% of the portfolio, ranked #2725.

BlackRock Group first reported a position in VTVT in Q3 2015 and has held it in 6 quarters since. The position peaked at $237K in Q3 2016. 44 funds tracked by Wall St. Rank hold VTVT as of Q4 2016.

  • BlackRock Group held 823 shares of vTv Therapeutics worth $159K as of Q4 2016.
  • BlackRock Group left its vTv Therapeutics share count unchanged in Q4 2016.
  • vTv Therapeutics made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2725 holding.
  • BlackRock Group first reported a position in vTv Therapeutics in Q3 2015 and has held it in 6 quarters since.
  • BlackRock Group's vTv Therapeutics position peaked at $237K in Q3 2016.
  • 44 funds tracked by Wall St. Rank held vTv Therapeutics as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.